GNI Group Past Earnings Performance

Past criteria checks 4/6

GNI Group has been growing earnings at an average annual rate of 59.3%, while the Biotechs industry saw earnings growing at 19.3% annually. Revenues have been growing at an average rate of 26.9% per year. GNI Group's return on equity is 14.8%, and it has net margins of 31.7%.

Key information

59.3%

Earnings growth rate

57.4%

EPS growth rate

Biotechs Industry Growth	17.0%
Revenue growth rate	26.9%
Return on equity	14.8%
Net Margin	31.7%
Last Earnings Update	30 Sep 2024

Recent past performance updates

No updates

Recent updates

No updates

Revenue & Expenses Breakdown

How GNI Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:GNII.F Revenue, expenses and earnings (JPY Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Sep 24	22,655	7,186	16,609	2,709
30 Jun 24	23,647	6,766	16,231	2,723
31 Mar 24	27,752	9,550	15,935	2,610
31 Dec 23	26,010	8,094	15,293	2,557
30 Sep 23	25,204	1,525	13,024	2,502
30 Jun 23	23,360	1,370	12,379	2,709
31 Mar 23	17,691	35	11,154	2,712
31 Dec 22	17,418	388	10,966	2,545
30 Sep 22	15,915	848	9,953	2,417
30 Jun 22	14,379	801	9,047	2,240
31 Mar 22	12,751	985	8,223	2,080
31 Dec 21	12,690	1,066	7,959	2,015
30 Sep 21	12,356	2,086	7,188	1,805
30 Jun 21	11,858	1,955	6,645	1,525
31 Mar 21	11,520	1,558	6,252	1,438
31 Dec 20	9,773	1,258	5,180	1,243
30 Sep 20	9,066	367	4,806	1,056
30 Jun 20	8,407	247	4,502	1,036
31 Mar 20	7,996	194	4,498	839
31 Dec 19	7,446	181	4,334	758
30 Sep 19	6,734	147	3,853	658
30 Jun 19	6,279	154	3,706	585
31 Mar 19	5,581	258	3,290	567
31 Dec 18	5,018	-200	2,998	530
30 Sep 18	4,802	47	2,730	527
30 Jun 18	4,095	-130	2,401	413
31 Mar 18	3,310	-337	2,103	302
31 Dec 17	2,648	-175	1,740	268
30 Sep 17	1,939	-97	1,521	243
30 Jun 17	1,473	-111	1,261	238
31 Mar 17	1,347	-406	1,139	257
31 Dec 16	1,306	-513	1,118	274
30 Sep 16	1,117	-858	878	580
30 Jun 16	1,073	-956	979	519
31 Mar 16	1,093	-752	1,048	452
31 Dec 15	1,016	-623	1,049	379
30 Sep 15	928	-440	1,071	139
30 Jun 15	814	-360	963	139
31 Mar 15	651	-345	823	139
31 Dec 14	474	-327	715	139
30 Sep 14	334	-527	364	427
30 Jun 14	254	-787	511	427
31 Mar 14	202	-769	438	427
31 Dec 13	183	-730	367	427

Quality Earnings: GNII.F has a high level of non-cash earnings.

Growing Profit Margin: GNII.F's current net profit margins (31.7%) are higher than last year (6.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: GNII.F's earnings have grown significantly by 59.3% per year over the past 5 years.

Accelerating Growth: GNII.F's earnings growth over the past year (371.2%) exceeds its 5-year average (59.3% per year).

Earnings vs Industry: GNII.F earnings growth over the past year (371.2%) exceeded the Biotechs industry 16.6%.

Return on Equity

High ROE: GNII.F's Return on Equity (14.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 00:41
End of Day Share Price	2024/12/13 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GNI Group Ltd. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Stephen Barker	Jefferies LLC
Yuriko Ishida	Mizuho Securities Co., Ltd.
Nia Dokova	Pelham Smithers Associates Ltd.